- Home
- TOVX vs FINS Comparison
TOVX vs FINS Comparison
Compare TOVX & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- FINS
- Stock Information
- Founded
- TOVX 2001
- FINS 2019
- Country
- TOVX United States
- FINS United States
- Employees
- TOVX N/A
- FINS N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- FINS Finance/Investors Services
- Sector
- TOVX Health Care
- FINS Finance
- Exchange
- TOVX Nasdaq
- FINS Nasdaq
- Market Cap
- TOVX 3.5M
- FINS 323.3M
- IPO Year
- TOVX 2006
- FINS N/A
- Fundamental
- Price
- TOVX $1.14
- FINS $12.78
- Analyst Decision
- TOVX Strong Buy
- FINS
- Analyst Count
- TOVX 1
- FINS 0
- Target Price
- TOVX $6.00
- FINS N/A
- AVG Volume (30 Days)
- TOVX 96.3K
- FINS 78.0K
- Earning Date
- TOVX 11-12-2024
- FINS 01-01-0001
- Dividend Yield
- TOVX N/A
- FINS 9.97%
- EPS Growth
- TOVX N/A
- FINS N/A
- EPS
- TOVX N/A
- FINS N/A
- Revenue
- TOVX N/A
- FINS N/A
- Revenue This Year
- TOVX N/A
- FINS N/A
- Revenue Next Year
- TOVX N/A
- FINS N/A
- P/E Ratio
- TOVX N/A
- FINS N/A
- Revenue Growth
- TOVX N/A
- FINS N/A
- 52 Week Low
- TOVX $1.14
- FINS $11.61
- 52 Week High
- TOVX $17.00
- FINS $12.57
- Technical
- Relative Strength Index (RSI)
- TOVX 36.15
- FINS 45.94
- Support Level
- TOVX $1.23
- FINS $12.82
- Resistance Level
- TOVX $1.21
- FINS $13.11
- Average True Range (ATR)
- TOVX 0.07
- FINS 0.11
- MACD
- TOVX 0.01
- FINS -0.01
- Stochastic Oscillator
- TOVX 0.00
- FINS 31.63
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.